Lorazepam and pentobarbital discrimination: Interactions with CGS 8216 and caffeine

Research output: Contribution to journalArticle

Abstract

Baboons and rats were trained under a two-lever, food-reinforced drug discrimination procedure. The training drug was either lorazepam (1.0 mg/kg) or pentobarbital (5.6 mg/kg in baboons, 10.0 mg/kg in rats). Under test conditions, a range of training drug doses occasioned 100% drug lever responding. CGS 8216 (3.2-10.0 mg/kg) combined with lorazepam produced a complete shift to the no-drug lever in both species; this shift was surmountable with higher doses of lorazepam. CGS 8216 (32.0 mg/kg) combined with pentobarbital produced a statistically significant decrease in drug-lever responding in rats, and in baboons CGS 8216 initially, but not subsequently, produced a complete shift to the no-drug lever. Caffeine (0.32-10.0 mg/kg) combined with lorazepam inconsistently decreased drug-lever responding across multiple determinations in baboons and significantly decreased drug lever responding in rats. Caffeine combined with pentobarbital also yielded an inconsistent decrease in drug lever responding in baboons but there was no effect in rats. Thus the most reliable and complete antagonism across species was obtained with the CGS 8216/lorazepam combinations.

Original languageEnglish (US)
Pages (from-to)169-181
Number of pages13
JournalEuropean Journal of Pharmacology
Volume107
Issue number2
DOIs
StatePublished - Jan 2 1985

Keywords

  • Drug discrimination CGS 8216 caffeine lorazepam pentobarbital

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Lorazepam and pentobarbital discrimination: Interactions with CGS 8216 and caffeine'. Together they form a unique fingerprint.

  • Cite this